Suppression of adjuvant arthritis in rats by induction of oral tolerance to mycobacterial 65-kDa heat shock protein

被引:58
作者
Haque, MA
Yoshino, S
Inada, S
Nomaguchi, H
Tokunaga, O
Kohashi, O
机构
[1] SAGA MED SCH,DEPT MICROBIOL,SAGA 849,JAPAN
[2] NATL INST LEPROSY RES,TOKYO,JAPAN
[3] SAGA MED SCH,DEPT PATHOL,SAGA,JAPAN
关键词
oral tolerance; adjuvant arthritis; heat-shock protein; adoptive transfer; regulatory T cell; Mycobacterium tuberculosis;
D O I
10.1002/eji.1830261116
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Oral administration of mycobacterial 65-kDa heat shock protein (HSP) given daily for 5 days prior to immunization with Mycobacterium tuberculosis (Mt) suppressed the development of adjuvant arthritis (AA) in rats. AA was significantly suppressed by 30 and 300 mu g HSP and variably by 0.3, 3 mu g or 1 mg. Histological analysis of joint samples obtained from control and test rats confirmed the suppression of AA in the fed group. Feeding Mt or hen egg lysozyme (HEL) failed to affect AA. indicating that the suppression was HSP specific. The oral administration of 30 mu g HSP decreased both delayed-type hypersensitivity (DTH) reactions and proliferative responses to HSP and Mt. In addition, the proliferation of lymph node cells (LNC) from Mt-sensitized rats was inhibited by the addition of spleen cells (SPC) from HSP-fed animals, possibly by the secretion of transforming growth factor (TGF)-beta. Spleen cells obtained from tolerized donors were capable of transferring the tolerance to naive recipients. These results demonstrate that feeding HSP is an effective way to suppress AA and that the suppression of AA may be mediated by regulatory T cells generated following oral administration of mycobacterial 65-kDa HSP.
引用
收藏
页码:2650 / 2656
页数:7
相关论文
共 34 条
[21]  
MILLER A, 1993, J IMMUNOL, V151, P7307
[22]  
MILLER SD, 1979, J IMMUNOL, V123, P2344
[23]  
MOWAT AM, 1982, IMMUNOLOGY, V45, P105
[24]  
NGAN J, 1978, J IMMUNOL, V120, P861
[25]  
NOMAGUCHI H, 1989, INT J LEPROSY, V57, P817
[26]  
RICHMAN LK, 1978, J IMMUNOL, V121, P2429
[27]  
THOLE JER, 1990, MOL BIOL MYCOBACTERI, P37
[28]  
THOMAS HC, 1974, IMMUNOLOGY, V27, P631
[29]   AUTOIMMUNITY TO TYPE-2 COLLAGEN - EXPERIMENTAL-MODEL OF ARTHRITIS [J].
TRENTHAM, DE ;
TOWNES, AS ;
KANG, AH .
JOURNAL OF EXPERIMENTAL MEDICINE, 1977, 146 (03) :857-868
[30]   EFFECTS OF ORAL-ADMINISTRATION OF TYPE-II COLLAGEN ON RHEUMATOID-ARTHRITIS [J].
TRENTHAM, DE ;
DYNESIUSTRENTHAM, RA ;
ORAV, EJ ;
COMBITCHI, D ;
LORENZO, C ;
SEWELL, KL ;
HAFLER, DA ;
WEINER, HL .
SCIENCE, 1993, 261 (5129) :1727-1730